UnitedHealth Group shares have recently experienced an upward movement with a return of higher volumes and volatility. This technical chart pattern suggests a continuation of the upward movement. Investors should benefit from the breakout of the $ 253 level to target the $ 272.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.
UnitedHealth Group accounts for 5.04 % of our USA Portfolio. A trade is currently open since 11/02/2015 with a purchase price of $ 119.36. Discover the other 19 stocks of the USA portfolio managed by the MarketScreener portfolio management team.
Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases.
Historically, the company has been releasing figures that are above expectations.
Analysts covering this company mostly recommend stock overweighting or purchase.
Stock prices approach a strong long-term resistance in weekly data at USD 248.78.
Below the resistance at 248.78 USD, the stock shows a negative configuration when looking looking at the weekly chart.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.